Fecal specimen collection in the clinical setting is often unfeasible for large population studies, especially because cancer patients on immunotherapy often experience constipation. A method for ...
Background. In 68% of foodborne disease outbreaks, no etiologic pathogen is identified. In two-thirds of outbreaks with no identified etiology, no stool specimens are submitted for testing. Methods.
Among survey respondents with IBD who had used the mail-order option, 90.5% said they would recommend using a mail-order kit for future stool sample collection, and 83% said they would be interested ...
Pairing diagnostic innovation with improved patient experience, ColoSense aims to streamline the screening process and increase compliance Geneoscopy, Inc., a life sciences company focused on ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Charlotte Schubert on Jun 3, 2021 at ...
Daniel McDonald and Jack Gilbert (both University of California, San Diego; CA, USA) discuss the challenges faced during fecal sample collection and highlight important factors to consider when ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
Credit: Reese Pharmaceutical. ColoTest is designed to detect blood in stool, which may be an early indication for colorectal cancer, diverticulitis, gastrointestinal disorders, colitis or polyps.